About the Company
iCAD Inc. (NASDAQ: ICAD) is a medical-device manufacturer. Headquartered in Nashua, New Hampshire, iCAD offers computer aided detection (CAD) to support detection of breast, prostate and colorectal cancers. The iCAD technology platforms also include hardware and software for radiation therapy treatment.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
447
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ICAD News
iCAD (ICAD) Price Target Decreased by 15.94% to 4.93
The average one-year price target for iCAD (NasdaqCM:ICAD) has been revised to 4.93 / share. This is an decrease of 15.94% ...
iCAD, Inc. (ICAD)
Reported EPS is $0.05, expectations were $-0.05. iCAD, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator ...
iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium
ProFound Cloud, powered by Google Cloud architecture and Google’s Health AI innovations, redefines accessibility to critical insights, empowering ...
iCAD Launches ProFound Cloud: Next-Gen AI Breast Health Platform
(NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, today announced commercial ...
iCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs)
iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, is proud to announce a philanthropic global health collaboration with RAD-AID International.
Icad Inc
What Is a Stock Market Correction? Investors may be shaken by a drop of 10% or more in a stock market index, but corrections are par for the course.
iCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs)
iCAD, Inc. (NASDAQ: ICAD) is a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered solutions that enable medical providers to ...
iCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs)
NASHUA, N.H., April 03, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, is proud to announce a philanthropic global ...
Loading the latest forecasts...